Oxygen Delivery During Cardiopulmonary Bypass And Inflammatory Reaction After Cardiac Surgery
OXYINFLAMM
1 other identifier
observational
908
1 country
2
Brief Summary
Cardiac surgery, especially when involving cardiopulmonary bypass (CPB), has long been associated with a systemic inflammatory response that can lead to a range of complications, from mild symptoms to severe organ dysfunction, and mortality. The exact mechanisms behind this response remain a topic of extensive research, but it's clear that the body's reaction to the extracorporeal circulation, combined with surgical trauma, plays a significant role. Factors such as genomics, age, specific preoperative conditions, and the duration of operations have been associated with significant clinical responses. A pivotal insight into this response comes from recent genome-wide transcriptional analyses. Perioperative ischemia and ischemia-reperfusion injury (IRI) have been suggested as hub-nodes in a hierarchic structure evaluating the response to cardiac surgery. This suggests that IRI isn't just a side effect of the surgery but might be a central player in the body's inflammatory response. The role of perioperative ischemia and its potential as a significant contributor to the postoperative inflammatory response cannot be understated. This study aims to delve deeper into the role of oxygen delivery and its implications in the systemic inflammatory response post- cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2023
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2025
CompletedFirst Submitted
Initial submission to the registry
May 12, 2025
CompletedFirst Posted
Study publicly available on registry
May 28, 2025
CompletedMay 28, 2025
May 1, 2025
1.2 years
May 12, 2025
May 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
SIRS
Systemic Inflammatory Reaction Syndrome (SIRS) as per the 1991 American College of Chest Physicians/Society of Critical Care Medicine criteria
12 hours after surgery
Secondary Outcomes (1)
Composite outcome
Up to 30 days
Eligibility Criteria
Adult cardiac surgery patients undergoing elective cardiopulmonary bypass-assisted procedures
You may qualify if:
- Adult patients (18-90 years)
- Elective surgery
- CPB-assisted
You may not qualify if:
- Age \< 18 or \> 90 years
- Infective endocarditis
- Hypothermia during surgery (\<34°C)
- Emergency surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Anthea Hospital
Bari, Italia, Italy
Santa Maria Hospital, GVM Care & Research
Bari, Italia, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
May 12, 2025
First Posted
May 28, 2025
Study Start
October 30, 2023
Primary Completion
December 31, 2024
Study Completion
January 31, 2025
Last Updated
May 28, 2025
Record last verified: 2025-05